Latest Hims News & Updates

See the latest news and media coverage for Hims. We track all announcements, press releases, and industry mentions in real time, all in one place.

Hims

Men's health telehealth provider

Last updated Today

Latest news about Hims

In short: Hims & Hers expanded its weight-loss portfolio through a Novo Nordisk partnership and the $1.15 billion acquisition of Eucalyptus.

Yesterday Hims

Hims launches Labs AI care agent

It embeds in the platform to clarify lab results, provide personalized insights, and connect customers to clinicians. Rollout begins now.
April 30 Hims

Hims launches Testosterone Rx+

It combines enclomiphene to double testosterone levels with nutrients like zinc and B-vitamins in a daily pill. Unlike TRT, it preserves natural production and fertility.
April 28 Hims

Hims & Hers nominates Kofi Amoo-Gottfried to its board

The marketing leader from DoorDash and Meta will join if elected at the 2026 shareholder meeting. The board size decreases to 9.
April 23 Hims

Hims & Hers offers full range of FDA-approved GLP-1s

Providers can prescribe Zepbound vials, KwikPen, and Foundayo to LillyDirect pharmacy with self-pay pricing. This expands access alongside comprehensive weight loss support.

Today MSN

HIMS stock slides after Amazon escalates GLP-1 war with Ozempic — AI healthcare bets in focus ahead of earnings

Amazon said customers can access real-time medication availability, transparent pricing, and same-day delivery. ・Citi previously noted that Amazon's healthcare model still differs from subscription-based telehealth...
Yesterday Fierce Healthcare

Hims & Hers debuts its first AI care agent to interpret biomarker lab results

Hims & Hers launched an artificial intelligence agent embedded in its platform to help interpret biomarker lab results and provide users personalized insights about their...
May 5 Yahoo Finance

Hims & Hers Expands DTC Platform to Broaden Access to Personal Care

HIMS broadens its DTC platform with GLP-1 access, a new Benefits hub and global expansion to broaden convenient, personalized care.
May 4 MSN

HIMS stock jumps overnight: CEO eyes heart attack prediction firm with 'unreal' value

Hims is expanding beyond telehealth with a push into hormone care, while building out at-home testing and virtual care services. ・Peptides is also seen as...

Never miss news about Hims

Track Hims and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Browse news for competitors to Hims and other trending companies.